Recognizing bedside rationing: Clear cases and tough calls

Annals of Internal Medicine

Volumn 126, Issue 1, 1997, Pages 74-80

  Ubel, Peter A ^a   Goold, Susan ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; CIPROFLOXACIN; CONTRAST MEDIUM; COTRIMOXAZOLE; HYDROCHLOROTHIAZIDE; PROSTATE SPECIFIC ANTIGEN;

ADULT; ALLERGIC RHINITIS; CASE REPORT; COST CONTROL; DOCTOR PATIENT RELATION; DRUG COST; FEMALE; HEALTH CARE COST; HEALTH SERVICE; HOSPITAL; HUMAN; HYPERTENSION; MALE; MORALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; URINARY TRACT INFECTION;

EID: 0031036098     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-126-1-199701010-00010     Document Type: Review

References (28)

1. Abrams FR. Patient advocate or secret agent? JAMA. 1986;256:1784-5.
2. Angell M. Cost containment and the physician. JAMA. 1985;254:1203-7.
3. Cassell EJ. Do justice, love mercy: the inappropriateness of the concept of justice applied to bedside decisions. In: Shelp EE, ed. Justice and Health Care. New York: D Reidel; 1981:75-82.
4. Hiatt HH. Protecting the medical commons: who is responsible? N Engl J Med. 1975;293:235-41.
5. Sulmasy DP. Physicians, cost control, and ethics. Ann Intern Med. 1992;116: 920-6.
6. Welch HG. Should the health care forest be selectively thinned by physicians or clear cut by payers? Ann Intern Med. 1991;115:223-6.
7. Ubel PA, Arnold RM. The unbearable rightness of bedside rationing. Physician duties in a climate of cost containment. Arch Intern Med. 1995;155: 1837-42.
8. Hall M. Rationing health care at the bedside. New York University Law Review. 1994;69:693-780.
9. Goold SD, Brody H. Rationing decisions in managed care settings: an ethical analysis. In: Misbin RI, Jennings B, Orentlicher D, Dewar M, eds. Health Care Crisis? The Search for Answers. Frederick, MD: Univ Publishing Group; 1995.
10. Morreim EH. Fiscal scarcity and the inevitability of bedside budget balancing. Arch Intern Med. 1989;149:1012-5.
11. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators. N Engl J Med. 1993; 329:673-82.
12. Alderman MH. Which antihypertensive drugs first - and why! JAMA. 1992; 267:2786-7.
13. Moser M. Current hypertension management: separating fact from fiction. Cleve Clin J Med. 1993;60:27-37.
14. Viberti G, Mogensen CE, Groop LC, Pauls JF. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group. JAMA. 1994;271:275-9.
15. Anspach RR. Deciding Who Lives: Fateful Choices in the Intensive-Care Nursery. Berkeley, CA: Univ of California Pr; 1993.
16. James W. The Will To Believe and Other Essays in Popular Philosophy. Cambridge, MA: Harvard Univ Pr; 1979.
17. Wolf AM, Nasser JF, Wolf AM, Schorling JB. The impact of informed consent on patient interest in prostate-specific antigen screening. Arch Intern Med. 1996;156:1333-6.
18. Ubel PA. Informed consent. From bodily invasion to the seemingly mundane [Editorial]. Arch Intern Med. 1996;156:1262-3.
19. Barry MJ, Mulley AG Jr, Fowler FJ, Wennberg JW. Watchful waiting vs immediate transurethral resection for symptomatic prostatism. The importance of patients' preferences. JAMA. 1988;259:3010-7.
20. Pauker SG, McNeil BJ. Impact of patient preferences on the selection of therapy. Journal of Chronic Diseases. 1981;34:77-86.
21. Grubbs NC, Schultz HJ, Henry NK, Ilstrup DM, Muller SM, Wilson WR. Ciprofloxacin versus trimethoprim-sulfamethoxazole: treatment of community-acquired urinary tract infections in a prospective, controlled, double-blind comparison. Mayo Clin Proc. 1992;67:1163-8.
22. Lipsitch M. Fears growing over bacteria resistant to antibiotics. New York Times. 12 September 1995:C1.
23. Ubel PA, Arnofd RM, Caplan AL. Rationing failure. The ethical lessons of the retransplantation of scarce vital organs. JAMA. 1993;270:2469-74.
24. Ubel P, Loewenstein G. The role of decision analysis in informed consent: choosing between intuition and systematicity. Social Science and Medicine. [In press].
25. Steinberg EP, Moore RD, Powe NR, Gopalan R, Davidoff AJ, Litt M, et al. Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography. N Engl J Med. 1992;326:425-30.
26. Eddy DM. Clinical decision making: from theory to practice. Applying cost-effectiveness analysis. The inside story. JAMA. 1992;268:2575-82.
27. Hochla PK, Tuason VB. Pharmacy and Therapeutics Committee: cost-containment considerations. Arch Intern Med. 1992;152:1773-5.
28. Garland MJ. Rationing in public: Oregon's priority-setting methodology. In: Strosberg MA, Wiener JM, Baker R, Fein IA, eds. Rationing America's Medical Care: The Oregon Plan and Beyond. Washington, DC: Brookings Institution; 1992.